|
Bruce Beutler answers a
few questions about this month's fast breaking paper in the field of
Immunology.
From
>>December 2004
Field:
Immunology
Article Title: How we detect microbes and respond to them: the Toll-like receptors and their transducers
Authors: Beutler,
B;Hoebe, K;Du, X;Ulevitch, RJ
Journal: J LEUKOCYTE BIOL
Volume: 74
Page: 479-485
Year: OCT 2003
* Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
* Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.
|
Why
do you think your paper is highly cited?
|

The Toll-like receptors
(TLRs) are the principal source of host
awareness of infection.
|
|
The Toll-like receptors (TLRs) are the principal source of
host awareness of infection. They sense lipopolysaccharides
(LPS), double-stranded RNA, unmethylated DNA, bacterial
lipopeptides, glucans, and other molecules of microbial origin.
Their discovery as such has been one of the key advances in
immunology during the last decade. Our paper reviews the
discovery itself, tells what has been learned of TLR signaling
through forward and reverse genetic methods, and offers insight
into the practical developments that may flow from our new
understanding.
The TLRs are highly cross-disciplinary in their importance,
and this likely explains the popularity of the review. Because
they are fundamentally innate immune sensors, the TLRs fill a
large gap in the picture of how innate immune cells recognize
infection. The TLRs are ultimately responsible for most things
that befall the host when an infection is present, including the
sepsis syndrome, shock, and sometimes death. The innate immune
system serves an adjuvant effect in activating the adaptive
immune system, and the TLRs also, in part, explain adjuvanticity.
Does
it describe a new discovery or a new methodology that's useful to
others?
Yes. The prospect for blocking TLR signaling for the
treatment of the symptoms of infection or inflammatory disease,
and the possibility that autoimmune diseases may involve
endogenous ligands for the TLR, are being actively considered as
therapeutic approaches.
Could
you summarize the significance of your paper in layman's terms?
We have described how the host immune system
"knows" that an infection is present, and the
biochemical pathways that are activated by this awareness.
How
did you become involved in this research?
Both Bruce Beutler and Richard J. Ulevitch are longstanding
endotoxin (lipopolysaccharide; LPS) researchers, and LPS has
been taken as a model inducer of innate immune responses for
more than a century. Richard J. Ulevitch discovered that CD14
was a biologically relevant LPS receptor on mammalian cells.
Bruce Beutler discovered the function of TLR4 as the
transmembrane component of the LPS receptor. This led directly
to the discovery that the TLRs sense discrete molecules of
microbial origin and initiate the innate immune response.
Bruce Beutler, M.D.
Professor, Department of Immunology
The Scripps Research Institute
La Jolla, CA, USA
Read
comments by author Bruce Beutler
for another Fast Breaking Paper in Immunology from August 2004.
|
ESI Special Topics,
December 2004
Citing URL - http://www.esi-topics.com/fbp/2004/X
|
|